Longitudinal investigation of gait and Alzheimer's disease in adults with Down syndrome
Alzheimer's & Dementia · 2025
DOI: 10.1002/alz.70211 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alzheimer's & Dementia, 2025. Verfasst von Ashlyn Barry und 27 weiteren Autor:innen. Beteiligte Einrichtung: Waisman Center, University of Wisconsin-Madison, Madison, Wisconsin, USA. Hauptthemen laut MEDLINE: Down Syndrome, Alzheimer Disease, Gait, Gait Disorders, Neurologic. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS, NICHD NIH HHS, NCATS NIH HHS.
Themen: Demenz
Abstract (Originalsprache)
INTRODUCTION Gait abnormalities are associated with Alzheimer's disease (AD) in the general population, but it is unclear if the same is true for individuals with Down syndrome (DS). This study examined gait across 32 months in relation to neuroimaging biomarkers (amyloid beta [Aβ], neurofibrillary tangles [NFTs], and hippocampal volume), cognitive decline, and clinical AD status in adults with DS. METHODS Participants were 218 adults with DS who underwent Aβ and NFT positron emission tomography (PET) and magnetic resonance imaging (MRI) scans, cognitive testing, and gait assessments at baseline and 32 months. Residual change regression models were conducted. RESULTS Higher baseline Aβ PET and NFT PET and lower MRI hippocampal volume were associated with gait declines across 32 months. Cognitive declines were associated with gait declines. Participants with clinical dementia at 32 months had greater gait decline than those who were cognitively stable. DISCUSSION Gait impairments are a key feature of DS‐associated AD (DSAD). Gait assessments could offer a quick, cost‐effective, non‐invasive screen for DSAD. Highlights Those with clinical status of dementia had lower gait performance than those who were cognitively stable. Higher baseline amyloid beta and neurofibrillary tangle volume was associated with more gait impairments. Lower baseline hippocampal volume was associated with more gait impairments. Greater decline in gait performance was associated with cognitive decline. Greater decline in gait performance was associated with more dementia symptoms.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Waisman Center, University of Wisconsin-Madison, Madison, Wisconsin, USA.
- Behavioral Health Service Line, VA Pittsburgh Healthcare System, Pittsburgh, Pennsylvania, USA.
- Department of Psychiatry, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
- New York Institute for Basic Research in Developmental Disabilities, Department of Psychology, Staten Island, New York, USA.
- Deparment of Psychiatry & Human Behavior, University of California, Irvine, Irvine, California, USA.
- Department of Psychiatry, University of Cambridge, Cambridge, UK.
ORCID-Profile: Ashlyn Barry
Förderung
- NIA NIH HHS
- NICHD NIH HHS
- NCATS NIH HHS
- Alzheimer's Disease Research Centers Program
- National Centralized Repository for Alzheimer Disease and Related Dementias
- DS-Connect
- National Institute on Aging and the National Institute for Child Health and Human Development
- National Center for Advancing Translational Sciences
Zitieren
APA
Barry, A., Peven, J. C., Handen, B. L., Bolt, D., Krinsky-McHale, S. J., Hom, C. L., Clare, I. C. H., Glueck, A., Harp, J., Schmitt, F., Zammit, M., Minhas, D., Luo, W., Laymon, C., Price, J., Lee, J. H., Lott, I., Cohen, A., Ances, B. M., …, & Alzheimer Biomarker Consortium ‐ Down syndrome (2025). Longitudinal investigation of gait and Alzheimer's disease in adults with Down syndrome. Alzheimer's & Dementia. https://doi.org/10.1002/alz.70211
Vancouver
Barry A, Peven JC, Handen BL, Bolt D, Krinsky-McHale SJ, Hom CL, et al. Longitudinal investigation of gait and Alzheimer's disease in adults with Down syndrome. Alzheimer's & Dementia. 2025. doi:10.1002/alz.70211
BibTeX
@article{Barry2025,
author = {Barry, Ashlyn and Peven, Jamie C and Handen, Benjamin L and Bolt, Daniel and Krinsky-McHale, Sharon J and Hom, Christy L and Clare, Isabel C H and Glueck, Amanda and Harp, Jordan and Schmitt, Frederick and Zammit, Matthew and Minhas, Davneet and Luo, Weiquan and Laymon, Charles and Price, Julie and Lee, Joseph H and Lott, Ira and Cohen, Annie and Ances, Beau M and Pulsifer, Margaret and Rosa, H Diana and Lai, Florencia and Zaman, Shahid H and Head, Elizabeth and Mapstone, Mark and Christian, Bradley T and Hartley, Sigan L and Alzheimer Biomarker Consortium ‐ Down syndrome, Alzheimer Biomarker Consortium ‐ Down syndrome},
title = {Longitudinal investigation of gait and Alzheimer's disease in adults with Down syndrome},
journal = {Alzheimer's & Dementia},
year = {2025},
doi = {10.1002/alz.70211}
}
EUVIMED